
Hepatologist

No OPD information available
Autoimmune Hepatitis
Cirrhosis
Hepatitis
Hepatitis C
Liver Cancer
Liver Transplant
Non-Alcoholic Fatty Liver Disease
Alcoholic Cirrhosis
Cholangitis
Cholestasis
Common Variable Immune Deficiency
Liver Failure
Mucormycosis
Nocardiosis
Portal Hypertension
Pulmonary Nocardiosis
Sclerosing Cholangitis
Splenomegaly
Thrombocytopenia
Gerry C. Macquillan is a medical professional who helps people with liver and immune system problems. Some of the things they can help with are Autoimmune Hepatitis, Cirrhosis, Hepatitis, Liver Cancer, and more.
Gerry C. Macquillan uses special skills and treatments to take care of patients. They know a lot about liver diseases and how to treat them. Patients trust Gerry C. Macquillan because they are good at explaining things and listening to their concerns.
To stay updated with the latest medical knowledge, Gerry C. Macquillan reads a lot of research and attends conferences. This helps them provide the best care for their patients.
Gerry C. Macquillan works well with other medical professionals. They have good relationships with colleagues and often collaborate on cases to give patients the best care possible.
One way Gerry C. Macquillan has helped patients is through a study published in the Journal of gastroenterology and hepatology. This study looked at the natural history and predictors of outcomes in autoimmune liver diseases, helping doctors better understand and treat these conditions.
Gerry C. Macquillan also conducted a clinical trial to assess the efficacy and safety of a treatment for transplant recipients with cytomegalovirus infections. This trial provided valuable information that can improve the care of patients with this condition.
In summary, Gerry C. Macquillan is a dedicated medical professional who uses their expertise to help patients with liver and immune system problems. Through research, clinical trials, and collaboration with colleagues, they make a positive impact on patients' lives and health.
Enrollment Status: Completed
Published: November 03, 2021
Intervention Type: Drug
Study Drug:
Study Phase: Phase 3
